Cellumed Inc is a leading biotech company dedicated to developing bone graft substitution based on human tissue graft.
Moreover, the company concentrates its R&D efforts on bio-similar business that develops human recombinant protein for treatment, employing genetic recombination technology.
We are in pursuit of high value products with advanced biotechnology.
Cellumed is the most prominent biotech company in Korea.
Acetechno Tower IX 402 Gasan-dong, Geumcheon-gu
Gwangjin-gu, Seoul - Special City
153-782 Korea South
Old Korea Bone Bank Co., Ltd. - Cellumed Co., LTD. -owns Endotec